Form 4 Tracker
RHYTHM PHARMACEUTICALS, INC.
RYTM

35 insider filings · Latest: Jun 23, 2026

Common Stock Transactions
Txn DateAcceptedInsiderTypeSharesAvg PriceValueShares OwnedFiling
Mar 14, 2025Mar 14 8:21 PMYANN MAZZABRAUD
Proposed Sale
75,000$50.24$3.8M

View →

Feb 13, 2025Feb 13 9:31 PMJENNIFER KAYDEN LEE
Proposed Sale
1,205$57.64$69.5K

View →

Feb 12, 2025Feb 12 9:42 PMJENNIFER KAYDEN LEE
Proposed Sale
1,205$57.58$69.4K

View →

Feb 10, 2025Feb 10 9:34 PMJENNIFER KAYDEN LEE
Proposed Sale
4,189$59.18$247.9K

View →

Feb 5, 2025Feb 5 9:20 PMJENNIFER KAYDEN LEE
Proposed Sale
3,066$59.95$183.8K

View →

Nov 7, 2024Nov 7 9:36 PMPAMELA CRAMER
Proposed Sale
4,688$62.65$293.7K

View →

Nov 6, 2024Nov 6 10:07 PMPAMELA CRAMER
Proposed Sale
4,687$56.25$263.6K

View →

Sep 17, 2024Sep 17 8:42 PMJENNIFER GOOD
Proposed Sale
31,751$49.52$1.6M

View →

Sep 10, 2024Sep 10 8:22 PMLYNN TETRAULT393 COMMONWEALTH AVE
Proposed Sale
17,501$50.66$886.6K

View →

Sep 9, 2024Sep 9 8:31 PMJENNIFER GOOD
Proposed Sale
16,749$49.25$824.9K

View →

Aug 26, 2024Aug 26 8:27 PMJENNIFER GOOD
Proposed Sale
35,000$46.12$1.6M

View →

Aug 26, 2024Aug 26 8:27 PMLYNN TETRAULT393 COMMONWEALTH AVE
Proposed Sale
7,499$46.12$345.9K

View →

Aug 26, 2024Aug 26 8:26 PMPAMELA CRAMER
Proposed Sale
7,299$46.12$336.6K

View →

Nov 11, 2024JOSEPH J SHULMAN
Proposed Sale
13,281$67.33$894.2K

View →

Nov 11, 2024JENNIFER KAYDEN LEE
Proposed Sale
66,861$67.33$4.5M

View →

← Previous

Page 3 of 3

Stock Options & Derivatives
Txn DateAcceptedInsiderTypeSharesExercise PriceShares OwnedFiling
Feb 11, 2026Feb 13 10:53 PMJoseph ShulmanChief Technical Officer
Grant/Award
37,500$98.4722,500(D)

View →

Feb 11, 2026Feb 13 10:52 PMDavid P MeekerDirector, President and CEO
Grant/Award
179,750$98.47107,850(D)

View →

Feb 11, 2026Feb 13 10:50 PMYann MazabraudEVP, Head of International
Grant/Award
23,35023,350(D)

View →

Feb 11, 2026Feb 13 10:49 PMJennifer Kayden LeeEVP, Head of North America
Grant/Award
54,150$98.4732,500(D)

View →

Feb 11, 2026Feb 13 10:48 PMChristopher Paul GermanCorporate Controller & CAO
Grant/Award
5,2155,215(D)

View →

Feb 11, 2026Feb 13 10:47 PMAlastair GarfieldChief Scientific Officer
Grant/Award
41,650$98.4725,000(D)

View →

Feb 11, 2026Feb 13 10:45 PMPamela J. CramerChief Human Resources Officer
Grant/Award
29,150$98.4717,500(D)

View →

Feb 11, 2026Feb 13 1:56 AMHunter C SmithChief Financial Officer
Grant/Award
62,500$98.4737,500(D)

View →

Feb 1, 2026Feb 3 9:38 PMYann MazabraudEVP, Head of International
Option Exercise
5,50011,000(D)

View →

Feb 1, 2026Feb 3 9:36 PMHunter C SmithChief Financial Officer
Option Exercise
26,00031,237(D)

View →

Feb 1, 2026Feb 3 9:35 PMJoseph ShulmanChief Technical Officer
Option Exercise
16,96818,750(D)

View →

Feb 1, 2026Feb 3 9:34 PMDavid P MeekerDirector, President and CEO
Option Exercise
68,713100,012(D)

View →

Feb 1, 2026Feb 3 9:33 PMJennifer Kayden LeeEVP, Head of North America
Option Exercise
22,61227,487(D)

View →

Feb 1, 2026Feb 3 9:32 PMChristopher Paul GermanCorporate Controller & CAO
Option Exercise
3,6135,418(D)

View →

Feb 1, 2026Feb 3 9:31 PMAlastair GarfieldChief Scientific Officer
Option Exercise
6,66319,987(D)

View →

Feb 1, 2026Feb 3 9:30 PMPamela J. CramerChief Human Resources Officer
Option Exercise
13,29315,000(D)

View →

← Previous

Page 2 of 2